US 11981739
Chimeric antigen receptor specific for interleukin-23 receptor
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 11981739 (Chimeric antigen receptor specific for interleukin-23 receptor) held by SANGAMO THERAPEUTICS FRANCE expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANGAMO THERAPEUTICS FRANCE
- Grant date
- Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K40/11